ABSTRACT
Percutaneous transluminal coronary angioplasty (PTCA) has been an accepted alternative to surgical revascularization in selected cases, since its introduction by Andres Gruntzig 25 years ago.1 The major limitation of this technique is restenosis; the use of endovascular stents have definitely improved the late patency for percutaneous procedures but recurrent stenosis remains a significant limitation.
